Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

NCT03068819 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: CIML NK Cell Infusion
PROCEDURE: CD3+ T Cell Product Infusion
PROCEDURE: Leukapheresis

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]